Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04533035
Other study ID # 5101143
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 28, 2020
Est. completion date February 26, 2021

Study information

Verified date March 2021
Source Kuopio University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In acute lower limb ischemia the main goal of the treatment is to restore the blood before irreversible damage to the soft tissues of the limb. Delays in identifying acute lower limb ischemia may lead to limb loss or lead to the loss of the patient. Situations in which the patient is unable to express symptoms of the acute lower limb ischemia, such as during general anesthesia, in intensive care, or immediately after vascular surgery, are challenging for medical staff to identify. A reliable, easy-to-use and non-invasive monitoring method is not yet in every day use. The aim of this study is to demonstrate that Near InfraRed Spectroscopy (NIRS) monitoring is such a monitoring method. Tourniquet induced ischemia is often used in hallux valgus surgery because it offers a bloodless view of the anatomical structures. In our study we will measure the soft tissue perfusion (rSO2) of the lower limbs during the whole operation. The sensors based on near-infrared spectroscopy will be located to the tibial surface and will record the normal state before the start of the tourniquet, during the tourniquet and also in the recovery phase. The hypothesis is that rSO2 decreases linearly as a function of time from the beginning of the tourniquet induced ischemia and the recovery time depends on the duration of the tourniquet. In our study the patients will be operated under a spinal anesthesia. We also hypothesise that rSO2 increases due to the induction of the spinal anesthesia. Our goal is to define the percentual decline of rSO2 that is significant for lower limb ischemia and also its time response to induction of ischemia.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date February 26, 2021
Est. primary completion date February 26, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Patient understands the meaning of the study and related measures. - Patient gives his or her written informed consent. - A tourniquet is used. - The procedure is performed under spinal anesthesia. - Body mass index under 40. Exclusion Criteria: - Patient belongs to any of the following special groups: disabled people, minor, pregnant or breast feeding women, convicts, forensic psychiatric patients. - Previous lower limb vascular surgery. - Previous lower limb deep vein thrombosis. - Previously performed tibial fasciotomies. - Any another reason why the researcher considers that the patient is not suitable for the study.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Finland Kuopio University Hospital Kuopio

Sponsors (1)

Lead Sponsor Collaborator
Kuopio University Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary The percentual decrease of the regional oxygen saturation in the lower limb 15 minutes after the tourniquet is applied. 50% decrease from baseline NIRS value in 15 minutes 15 minutes from tourniquet application
Secondary The time that the regional oxygen saturation in the lower limb takes to recover after the tourniquet is released. The time to NIRS value to reach baseline value after tourniquet is released From the moment tourniquet is released to the point that NIRS value reaches it's baseline or patient is mobilised in the recovery room, whichever came first, assessed up to two hours.
Secondary The percentual increase of the regional oxygen saturation in the lower limbs due to the induction of a spinal anesthesia. 10% increase in NIRS value after 30 minutes after spinal anesthesia induction 30 minutes from induction of spinal anesthesia
See also
  Status Clinical Trial Phase
Withdrawn NCT02408991 - Use Art-assist and Neupogen to Treat Chronic Limb Ischemia Phase 4
Completed NCT02369809 - Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Ischemia Phase 4
Not yet recruiting NCT05569369 - Endovascular Management of Combined Common Femoral and Superficial Femoral Arteries Lesions N/A
Active, not recruiting NCT02856230 - An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK) Phase 2/Phase 3
Not yet recruiting NCT03295539 - Acute Limb Ischaemia (ALI) Management With 'Indigo' Mechanical Aspiration System N/A
Not yet recruiting NCT04277702 - Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease Phase 3
Not yet recruiting NCT06226844 - Can the BeatMove Device Help Patients With Obliterative Arterial Disease of the Lower Limbs?
Recruiting NCT02304588 - Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot Phase 1
Recruiting NCT01937416 - Autologous Bone Marrow Mononuclear Cells Therapy in Diabetic Lower Limb Ischemia Phase 1
Completed NCT05601349 - TeleEducation for Implementing a Clinical Practice Guideline For Amputees N/A
Active, not recruiting NCT01305863 - Feasibility Study of the TGI Adipose-derived Stromal Cell (ASC)-Coated ePTFE Vascular Graft N/A
Recruiting NCT06416644 - The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) N/A
Completed NCT03910062 - Lower Limb Surveillance During VA-ECLS